ReNeuron Group

February 20, 2019

Reneuron eyes a partner with new stem cell data

Promising retinitis pigmentosa results have given Reneuron a boost, but the company still faces a pivotal trial.

January 29, 2019

Sanbio brings its Japanese retail fans down to earth

The heavily promoted company’s cell therapy fails a key study in ischaemic stroke.

July 11, 2018

Deal hopes revive Reneuron

After years in the wilderness, the UK cell therapy specialist Reneuron could be about to seal a deal with a big US player.

February 13, 2018

Therapy focus – Never mind Tysabri in stroke, here’s BIIB093

December 05, 2016

Reneuron keeps faith with stem cell stroke project

November 18, 2016

Upcoming events – Reneuron’s time to deliver and Kadmon targets metastases

October 29, 2014

Poor industry scorecard drives desmoteplase rescue plan

October 12, 2010

Behind disappointment stem cell therapy showing pluripotential